Patents by Inventor Wei-Guo Su

Wei-Guo Su has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120264739
    Abstract: Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.
    Type: Application
    Filed: December 30, 2010
    Publication date: October 18, 2012
    Inventors: Wei-Guo Su, Hong Jia, Guangxiu Dai
  • Publication number: 20120245178
    Abstract: Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.
    Type: Application
    Filed: April 10, 2012
    Publication date: September 27, 2012
    Inventors: Wei-Guo SU, Hong JIA, Guangxiu DAI
  • Publication number: 20120238572
    Abstract: Quinazoline derivatives of the following formula: wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, and Z are defined herein. It also discloses a method of treating an angiogenesis-related disorder with one of these compounds.
    Type: Application
    Filed: June 4, 2012
    Publication date: September 20, 2012
    Inventors: Wei-Guo Su, Weihan Zhang, Xiaoqiang Yan, Yumin Cui, Yongxin Red, Jifeng Duan
  • Patent number: 8212033
    Abstract: Quinazoline derivatives of the following formula: wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, and Z are defined herein. It also discloses a method of treating an angiogenesis-related disorder with one of these compounds.
    Type: Grant
    Filed: September 29, 2010
    Date of Patent: July 3, 2012
    Assignee: Hutchison Medipharma Enterprises Limited
    Inventors: Wei-Guo Su, Weihan Zhang, Xiaoqiang Yan, Yumin Cui, Yongxin Ren, Jifeng Duan
  • Publication number: 20110015213
    Abstract: Quinazoline derivatives of the following formula: wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, and Z are defined herein. It also discloses a method of treating an angiogenesis-related disorder with one of these compounds.
    Type: Application
    Filed: September 29, 2010
    Publication date: January 20, 2011
    Inventors: Wei-Guo Su, Weihan Zhang, Xiaoqiang Yan, Yumin Cui, Yongxin Ren, Jifeng Duan
  • Patent number: 7868001
    Abstract: A compound of Formula I: Each variable is defined in the specification. This invention relates to a method of decreasing a level of a cytokine (e.g., TNF? or interlukine such as IL-1?) in a subject with a compound of Formula I. It also relates to a method of treating a disorder mediated by an overproduction of a cytokine with such a compound.
    Type: Grant
    Filed: November 2, 2007
    Date of Patent: January 11, 2011
    Assignee: Hutchison Medipharma Enterprises Limited
    Inventors: Wei Deng, Wei-Guo Su, Yu Cai, Jeff Duan
  • Patent number: 7829574
    Abstract: Substituted quinazoline compounds of the following formula: wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, and X are defined herein. It also discloses a pharmaceutical composition containing one of these compounds.
    Type: Grant
    Filed: May 9, 2008
    Date of Patent: November 9, 2010
    Assignee: Hutchison MediPharma Enterprises Limited
    Inventors: Wei-Guo Su, Weihan Zhang, Xiaoqiang Yan, Yumin Cui, Yongxin Ren, Jifeng Duan
  • Patent number: 7737157
    Abstract: Pyrimidine compounds of the following formula: wherein R1, R2, R3, R4, R5, X, Q1, Q2, and Q3 are defined herein. Also disclosed is a method of treating cancer with one of these compounds.
    Type: Grant
    Filed: August 29, 2008
    Date of Patent: June 15, 2010
    Assignee: Hutchison MediPharma Enterprises Limited
    Inventors: Wei-Guo Su, Hong Jia, Rick B. Ye, Yang Sai
  • Publication number: 20100056512
    Abstract: Pyrimidine compounds of the following formula: wherein R1, R2, R3, R4, R5, X, Q1, Q2, and Q3 are defined herein. Also disclosed is a method of treating cancer with one of these compounds.
    Type: Application
    Filed: August 29, 2008
    Publication date: March 4, 2010
    Applicant: Hutchison MediPharma Enterprises Limited
    Inventors: Wei-Guo Su, Hong Jia, Rick B. Ye, Yang Sai
  • Publication number: 20100009958
    Abstract: Quinazoline derivatives of the following formula: wherein R1, R2, R3, R4, R5, X, Y, and Z are defined herein. It also discloses a method of treating cancer with one of these compounds.
    Type: Application
    Filed: June 30, 2008
    Publication date: January 14, 2010
    Applicant: Hutchison MediPharma Enterprises Limited
    Inventors: Weihan Zhang, Wei-Guo Su, Haibin Yang, Yumin Cui, Yongxin Ren, Xiaoqiang Yan
  • Patent number: 7622465
    Abstract: Disclosed are methods for inhibiting TNF? expression, IL-1? expression, iNOS expression, and NF-?B activity and methods for treating autoimmune disease, cancer, or atherosclerosis with a compound of the following formula:
    Type: Grant
    Filed: December 16, 2008
    Date of Patent: November 24, 2009
    Assignee: Hutchison Medipharma Enterprises Limited
    Inventors: Wei-Guo Su, Hong Jia, Xiaoqiang Yan, Jifeng Duan, Tao Wang, Yu Cai, Weihan Zhang
  • Publication number: 20090281130
    Abstract: Quinazoline derivatives of the following formula: wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, and Z are defined herein. It also discloses a method of treating an angiogenesis-related disorder with one of these compounds.
    Type: Application
    Filed: May 9, 2008
    Publication date: November 12, 2009
    Applicant: Hutchison Medipharma Enterprises Limited
    Inventors: Wei-Guo Su, Weihan Zhang, Xiaoqiang Yan, Yumin Cui, Yongxin Ren, Jifeng Duan
  • Publication number: 20090118292
    Abstract: A compound of Formula I: Each variable is defined in the specification. This invention relates to a method of decreasing a level of a cytokine (e.g., TNF? or interlukine such as IL-1?) in a subject with a compound of Formula I. It also relates to a method of treating a disorder mediated by an overproduction of a cytokine with such a compound.
    Type: Application
    Filed: November 2, 2007
    Publication date: May 7, 2009
    Applicant: Hutchison Medipharma Enterprises Limited
    Inventors: Wei Deng, Wei-Guo Su, Yu Cai, Jeff Duan
  • Publication number: 20080255172
    Abstract: A compound of the following formula: wherein R1, R2, R3, R4, R5,T, U, V, X, Y, Z, G, and Z are defined herein. It also discloses a method of treating an angiogenesis-related disorder, e.g., cancer or age-related macular degeneration, with such a compound.
    Type: Application
    Filed: April 16, 2008
    Publication date: October 16, 2008
    Applicant: Hutchison MediPharma Enterprises Limeted
    Inventors: Wei-Guo Su, Hong Jia, Weihan Zhang, Yumin Cui, Xiaoqiang Yan, Yongxin Ren, Jifeng Duan, Yang Sai
  • Patent number: 6849608
    Abstract: A macrolide antibiotic of the formula wherein the variables are defined as described herein.
    Type: Grant
    Filed: June 3, 2003
    Date of Patent: February 1, 2005
    Assignee: Pfizer, Inc.
    Inventors: Wei-Guo Su, Yan Chen
  • Publication number: 20040209929
    Abstract: Fused heteroarylcarboxylic acids of formula (I): 1
    Type: Application
    Filed: February 19, 2004
    Publication date: October 21, 2004
    Applicant: Agouron Pharmaceuticals, Inc.
    Inventors: Donald Skalitzky, Wei-Guo Su, Luke Raymond Zehnder
  • Patent number: 6777543
    Abstract: The invention relates to compounds of the formula and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein R1, R2, R3, R4, R5, R17, Rf, A, X, and Y are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formulas 1, methods of using the compounds of formula 1 in the treatment of infections and methods of preparing the compounds of formula 1.
    Type: Grant
    Filed: May 19, 2003
    Date of Patent: August 17, 2004
    Assignee: Pfizer, Inc.
    Inventors: Yong-Jin Wu, Wei-Guo Su, Takushi Kaneko, Hamish McArthur
  • Publication number: 20040009930
    Abstract: A macrolide antibiotic of the formula 1
    Type: Application
    Filed: June 3, 2003
    Publication date: January 15, 2004
    Applicant: Pfizer Inc.
    Inventors: Wei-Guo Su, Yan Chen
  • Patent number: 6664238
    Abstract: This invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts and solvates thereof wherein X1, X2, R2, R15, R16 and R6 are as defined herein. The compounds of formula 1 are antibacterial and antiprotozoal agents that may be used to treat various bacterial and protozoal infections and disorders related to such infections. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of treating bacterial and protozoal infections by administering the compounds of formula 1.
    Type: Grant
    Filed: December 10, 1999
    Date of Patent: December 16, 2003
    Assignee: Pfizer Inc.
    Inventors: Wei-Guo Su, Takushi Kaneko, Yong-Jin Wu
  • Publication number: 20030229031
    Abstract: The invention relates to compounds of the formula 1
    Type: Application
    Filed: May 19, 2003
    Publication date: December 11, 2003
    Applicant: Pfizer Inc.
    Inventors: Yong-Jin Wu, Wei-Guo Su, Takushi Kaneko, Hamish McArthur